Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry
Results 481 - 500 out of 500 displayed.
« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
Reset ↻

Ethypharm announces the appointment of Éric CHEVALIER as Group Human Resources Director

Read more ››

By: PR Newswire Association LLC. - 04 Oct 2024

Related companies: Ethypharm Inc.

iD MyStyle® 3 and iD WorkStyle® 3 to Share HOYA's Best Technology Platform Lead by AdaptEase™ Technology

Read more ››

By: PR Newswire Association LLC. - 04 Oct 2024

NMRC Reports Results for Campylobacter Controlled Human Infection Model Study

Read more ››

By: GlobeNewswire - 04 Oct 2024

Related companies: Immuron Limited

Climb Bio to Present at William Blair’s Upcoming Conference Event on Transforming Autoimmune Diseases by Targeting CD19

Read more ››

By: GlobeNewswire - 04 Oct 2024

Amicus Therapeutics Announces Participation at the World Muscle Society Annual Congress 2024

Read more ››

By: GlobeNewswire - 04 Oct 2024

Related companies: Amicus Therapeutics, Inc.

Health Canada Approves Label Expansion for Telix’s Illuccix® to Include Patient Selection for PSMA-Targeted Therapy

Read more ››

By: GlobeNewswire - 04 Oct 2024

Related companies: Telix Pharmaceuticals Limited

Cartesian Therapeutics Announces New Employment Inducement Grants

Read more ››

By: GlobeNewswire - 04 Oct 2024

Related companies: Cartesian Therapeutics, Inc.

Lifecore Biomedical Raises $24.3 Million in Private Placement of Common Stock

Read more ››

By: GlobeNewswire - 04 Oct 2024

Related companies: Lifecore Biomedical, LLC

Onco360® Has Been Selected as The National Specialty Pharmacy Partner for Tevimbra® (tislelizumab-jsgr)

Read more ››

By: GlobeNewswire - 04 Oct 2024

Lifecore Biomedical Reports First Quarter of Fiscal 2025 Financial Results and Provides Corporate Update

Read more ››

By: GlobeNewswire - 04 Oct 2024

Related companies: Lifecore Biomedical, LLC

Humacyte Announces Pricing of $30.0 Million Registered Direct Offering

Read more ››

By: GlobeNewswire - 04 Oct 2024

Related companies: Humacyte, Inc.

Extendicare Announces Timing of 2024 Third Quarter Results and Conference Call

Read more ››

By: GlobeNewswire - 04 Oct 2024

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Read more ››

By: GlobeNewswire - 04 Oct 2024

Related companies: Taysha Gene Therapies, Inc.

Biodexa Provides Update on Progression Free and Overall Survival in Phase 1 Study of MTX110 in Recurrent Glioblastoma

Read more ››

By: GlobeNewswire - 04 Oct 2024

Related companies: Biodexa Pharmaceuticals PLC

CytoDyn Engages Syneos Health as CRO For Its Phase II Oncology Trial

Read more ››

By: GlobeNewswire - 04 Oct 2024

Related companies: CytoDyn, Inc.

Sonnet BioTherapeutics to Receive Non-Dilutive Funding Through New Jersey Tax Certificate Transfer and Australia R&D Tax Incentive Programs

Read more ››

By: GlobeNewswire - 04 Oct 2024

Related companies: Sonnet BioTherapeutics, Inc.

IO Biotech Announces Two Poster Presentations at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting

Read more ››

By: GlobeNewswire - 04 Oct 2024

Related companies: IO Biotech, Inc.

Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting

Read more ››

By: GlobeNewswire - 04 Oct 2024

Related companies: Cue Biopharma, Inc.

Werewolf Therapeutics to Present Posters at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting

Read more ››

By: GlobeNewswire - 04 Oct 2024

Related companies: Werewolf Therapeutics, Inc.

Lyell Immunopharma Announces the Acceptance Abstracts for Presentation at 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting

Read more ››

By: GlobeNewswire - 04 Oct 2024

Related companies: Lyell Immunopharma, Inc.

« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

to the top ↑